AcuCort is a pharmaceutical company. The company has developed and commercializes the drug Zeqmelit®, which is an oral film based on the cortisone substance dexamethasone, for rapid availability and relief of severe and acute allergic reactions, among other things. The goal is commercialization in the EU, the US and in selected key markets via licensees and distributors. The company is headquartered in Lund.

Quotes for AcuCort AB

Right Now

+/-
-0.018
%
−3,01%
Latest
0.58
High
0.598
Low
0.571
Volume
256 741
Turnover (SEK)
149 957
Market Value (MSEK)
136,0
Time (Latest trade)
2025-11-04 17:29

Board

CEO

  • Jonas Jönmark

Chairperson of the Board

  • Ebba Fåhraeus

Board

  • Anna Eriksrud
  • Göran Tornling
  • Helen Ljungdahl Round
  • Jan Poulsen

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 30,69 30,69 2025-09-26
Jan Sören Poulsen 7,60 7,60 2025-09-26
Aqilion AB 3,31 3,31 2025-09-26
Olle Florén med bolag 2,61 2,61 2025-09-26
Bengt Schager 2,01 2,01 2025-09-26
Sven Jonmark 1,86 1,86 2025-09-26
Johan Thorell 1,59 1,59 2025-09-26
Nordnet Pensionsförsäkring 1,54 1,54 2025-09-26
Göran Ofsén 1,11 1,11 2025-09-26
Handelsbanken Liv Försäkring AB 1,02 1,02 2025-09-26
** Powered by Modular Finance

Insider trading

*Powered by Modular Finance

Key Numbers

*Compiled data from Millistream